CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) - USD ($) $ in Thousands	Total	Series A	Series B	Series C	IPO	Private Placement	Follow-on offering	Common Stock	Common Stock IPO	Common Stock Private Placement	Common Stock Follow-on offering	Additional Paid In Capital	Additional Paid In Capital IPO	Additional Paid In Capital Private Placement	Additional Paid In Capital Follow-on offering	Accumulated Deficit	Accumulated Other Comprehensive Loss
Beginning Balance at Dec. 31, 2020	$ (63,720)							$ 1				$ 1,421				$ (65,142)
Beginning Balance, Shares at Dec. 31, 2020								333,658
Temporary Equity, Beginning Balance at Dec. 31, 2020		$ 28,894	$ 85,367
Temporary Equity, Beginning balance, shares at Dec. 31, 2020		5,413,272	8,975,585
Issuance of Series C redeemable convertible preferred stock for cash, Value, net of transaction costs				$ 119,118
Issuance of Series C redeemable convertible preferred stock for cash, shares, net of transaction costs				10,396,707
Issuance of common stock from vesting / early exercise of restricted stock, value	8											8
Issuance of common stock from vesting / early excercise of restricted stock, shares								10,445
Exercise of stock options, value	432											432
Exercise of stock options, shares								200,107
Share-based compensation	6,754											6,754
Unrealized loss on investment	(20)																$ (20)
Net loss	(64,969)															(64,969)
Ending Balance at Dec. 31, 2021	(121,515)							$ 1				8,615				(130,111)	(20)
Ending Balance, shares at Dec. 31, 2021								544,210
Temporary Equity, Ending Balance at Dec. 31, 2021	233,379	$ 28,894	$ 85,367	$ 119,118
Temporary Equity, Ending balance, Shares at Dec. 31, 2021		5,413,272	8,975,585	10,396,707
Issuance of common stock, net of transaction costs, value					$ 127,283	$ 9,958	$ 120,719		$ 9	$ 1	$ 8		$ 127,274	$ 9,957	$ 120,711
Issuance of common stock , net of transaction costs, shares									9,487,500	590,318	8,050,000
Issuance of common stock from vesting / early exercise of restricted stock, value	122											122
Issuance of common stock from vesting / early excercise of restricted stock, shares								42,709
Conversion of preferred stock to common stock, value	233,379							$ 25				233,354
Conversion of preferred stock to common stock, shares								24,785,564
Temporary Equity, Conversion of stock, value		$ (28,894)	$ (85,367)	$ (119,118)
Temporary Equity, Conversion of stock, shares		(5,413,272)	(8,975,585)	(10,396,707)
Exercise of stock options, value	2,344											2,344
Exercise of stock options, shares								605,680
Share-based compensation	21,544											21,544
Unrealized loss on investment	(201)																(201)
Net loss	(188,679)															(188,679)
Ending Balance at Dec. 31, 2022	204,954							$ 44				$ 523,921				$ (318,790)	$ (221)
Ending Balance, shares at Dec. 31, 2022								44,105,981
Temporary Equity, Ending Balance at Dec. 31, 2022
Temporary Equity, Ending balance, Shares at Dec. 31, 2022		0	0	0